265 related articles for article (PubMed ID: 9675624)
1. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
Bagatin J; Rumboldt Z; Polić S; Sardelić S; Ljutić D; Capkun V; Pivac N; Petrović P; Bojić L
Lijec Vjesn; 1996; 118(1-2):11-6. PubMed ID: 8759414
[TBL] [Abstract][Full Text] [Related]
4. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
5. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
6. Long-acting and short-acting diuretics in the treatment of hypertension.
Pupita F; Belogi M; Ansuini R; Campolucci G
Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
[TBL] [Abstract][Full Text] [Related]
7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
8. Propranolol versus chlorthalidone--a prospective therapeutic trial in children with chronic hypertension.
Bachmann H
Helv Paediatr Acta; 1984 Mar; 39(1):55-61. PubMed ID: 6373679
[TBL] [Abstract][Full Text] [Related]
9. [Effect of long-term treatment with propranolol or hydrochlorothiazide on biochemical risk factors of coronary disease in patients with hypertension].
Witkowska M; Lukasik S; Kawecka M; Moszczyńska J; Karolko B
Kardiol Pol; 1989; 32 Suppl 2():25-32. PubMed ID: 2634150
[TBL] [Abstract][Full Text] [Related]
10. Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol.
Lefflerová K; Lupínek Z; Widimský J; Lupínková Z; Uhlír O; Miklis P; Zeman K; Zicha J
Cor Vasa; 1989; 31(5):387-93. PubMed ID: 2575480
[TBL] [Abstract][Full Text] [Related]
11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Kreeft JH; Larochelle P; Ogilvie RI
Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
[TBL] [Abstract][Full Text] [Related]
14. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
[TBL] [Abstract][Full Text] [Related]
15. Low-dose diuretic therapy for hypertension.
Moser M
Clin Ther; 1986; 8(5):554-62. PubMed ID: 3768929
[TBL] [Abstract][Full Text] [Related]
16. [The effect of the blood pressure lowering effect of bopindolol (Sandonorm) in patients with mild and moderate hypertension].
Zsáry A; Káldi N; Kállay K
Orv Hetil; 1991 Sep; 132(39):2149-51. PubMed ID: 1681490
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
[TBL] [Abstract][Full Text] [Related]
18. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
19. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
[TBL] [Abstract][Full Text] [Related]
20. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
Carpentiere G; Marino S; Castello F
Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
